de Lima JPS, Pinheiro MLB, Allaman IB, Silva-Jardim I. In vivo antileishmanial activity of Annona mucosa extracts.
Rev Soc Bras Med Trop 2020;
53:e20190139. [PMID:
31994657 PMCID:
PMC7083374 DOI:
10.1590/0037-8682-0139-2019]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2019] [Accepted: 10/04/2019] [Indexed: 11/22/2022] Open
Abstract
INTRODUCTION
Leishmaniasis, a disease caused by a parasite endemic to large areas of tropical and subtropical countries, is a growing public health problem.
METHODS
Male BALB/c mice were infected with Leishmania amazonensis and treated with extracts isolated from Annona mucosa.
RESULTS
Treated groups had significantly reduced footpad swelling. The group treated intraperitoneally with hexane extract showed footpad swelling similar to groups treated with Pentamidine® and Glucantime®. Groups treated with dichloromethane extract and hexane extract presented the recovering phenotype associated with reduced parasite levels.
CONCLUSIONS
Extracts of A. mucosa are promising sources of novel antileishmanial compounds.
Collapse